Alternative polyadenylation associated with prognosis and therapy in colorectal cancer

6Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Colorectal cancer (CRC) is among the most widely spread cancers globally. Aberrant alternative polyadenylation (APA) plays a role in cancer onset and its progression. Consequently, this study focused on highlighting the role of APA events and signals in the prognosis of patients with CRC. The APA events, RNA sequencing (RNA-seq), somatic mutations, copy number variants (CNVs), and clinical information of the CRC cohort were obtained from The Cancer Genome Atlas (TCGA) database and UCSC (University of California-Santa Cruz) Xena database. The whole set was sorted into two sets: a training set and a test set in a ratio of 7:3. 197 prognosis-related APA events were collected by performing univariate Cox regression signature in patients with CRC. Subsequently, a signature for APA events was established by least absolute shrinkage and selection operator (LASSO) and multivariate Cox analysis. The risk scores were measured for individual patients on the basis of the signature and patients were sorted into two groups; the high-risk group and the low-risk group as per their median risk scores. Kaplan–Meier curves, principal component analysis (PCA), and time-dependent receiver operator characteristic (ROC) curves revealed that the signature was able to predict patient prognosis effectively and further validation was provided in the test set and the whole set. The high-risk and low-risk groups displayed various distributions of mutations and CNVs. Tumor mutation burden (TMB) alone and in combination with the signature predicted the prognosis of CRC patients, but the gene frequencies of TMBs and CNVs did not change in the low- and high-risk groups. Moreover, immunotherapy and chemotherapy treatments showed different responses to PD-1 inhibitors and multiple chemotherapeutic agents in the low and high-risk groups based on the tumor immune dysfunction and exclusion (TIDE) and genomics of drugs sensitivity in cancer (GDSC) databases. This study may help in understanding the potential roles of APA in CRC, and the signature for prognosis-related APA events can work as a potential predictor for survival and treatment in patients with CRC.

References Powered by Scopus

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

75829Citations
N/AReaders
Get full text

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

35977Citations
N/AReaders
Get full text

Cytoscape: A software Environment for integrated models of biomolecular interaction networks

35074Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model

5Citations
N/AReaders
Get full text

Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivo

4Citations
N/AReaders
Get full text

APC mutations dysregulate alternative polyadenylation in cancer

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhang, Y., Xu, Y., & Wang, Y. (2022). Alternative polyadenylation associated with prognosis and therapy in colorectal cancer. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-11089-9

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

67%

Researcher 2

22%

Professor / Associate Prof. 1

11%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 8

89%

Medicine and Dentistry 1

11%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free